1. Home
  2. SEGG vs PMCB Comparison

SEGG vs PMCB Comparison

Compare SEGG & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SEGG

Lottery.com Inc.

N/A

Current Price

$1.03

Market Cap

4.5M

Sector

Technology

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$126.92

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SEGG
PMCB
Founded
2015
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.0M
IPO Year
2018
2001

Fundamental Metrics

Financial Performance
Metric
SEGG
PMCB
Price
$1.03
$126.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.8M
167.6K
Earning Date
11-02-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 70.56
N/A
EPS
N/A
★ N/A
Revenue
★ $6,779,057.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.42
$0.25
52 Week High
$4.65
$1.51

Technical Indicators

Market Signals
Indicator
SEGG
PMCB
Relative Strength Index (RSI) 38.19 98.99
Support Level $0.71 $0.60
Resistance Level $1.59 N/A
Average True Range (ATR) 0.36 0.17
MACD -0.01 0.42
Stochastic Oscillator 4.94 82.66

Price Performance

Historical Comparison
SEGG
PMCB

About SEGG Lottery.com Inc.

Sports Entertainment Gaming Global Corp is a world-wide sports, entertainment and gaming company operating at the intersection of digital content, fan engagement and regulated gaming. It is building an integrated ecosystem designed to connect fans to the games, events and experiences it care about in compliant, technology-enabled environments. It is operated as a single-reporting unit focused on its lottery and gaming platform, and its organizational structure, internal reporting systems, and resource allocation processes were aligned accordingly. The company owns and operates three premium domain brands: Sports.com, Concerts.com, and Lottery.com representing the company's three operating focuses: Sports, Entertainment, and Gaming.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: